• Amanda BergnerEmail author


Neurofibromatosis 1 (NF1) is one of the most common inherited neurologic diseases. NF1 is due to autosomal dominant mutations in the Nf1 gene; fifty percent of cases have de novo mutations. Mutations appear to be fully penetrant with intra- and inter-familial variability. Genetic counseling can be complicated by the possibility of mosaicism. People with NF1 often experience shame about their own condition and guilt of passing on the disorder. Genetic counseling should address the psychosocial aspects of the disease as well as the physical.


Genetic Testing Genetic Counselor Preimplantation Genetic Diagnosis Malignant Peripheral Nerve Sheath Tumor Genetic Test Result 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

Neurofibromatosis 1 (NF1) Part 1 (MOV 373,086 kb)

Neurofibromatosis 1 (NF1) Part 2 (MOV 297,172 kb)


  1. 1.
    Borofsky, S., & Levy, L. M. (2013). Neurofibromatosis: Types 1 and 2. American Journal of Neuroradiology, 13(4), 1071–1077. 10.3174/ajnr.A3534.
  2. 2.
    Boyd, K. P., Korf, B. R., & Theos, A. (2009). Neurofibromatosis type 1. Journal of the American Academy of Dermatology, 61(1), 1–14.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., et al. (2006). Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. Journal of Medical Genetics, 44(2), 81–88.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Vranceanu, A. M., Merker, V. L., Park, E., & Plotkin, S. R. (2013). Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: A systematic review of the literature. Journal of Neuro-Oncology, 114, 257–262. doi: 10.1007/s11060-013-1195-2.PubMedCrossRefGoogle Scholar
  5. 5.
    Uhlmann, E. J., & Plotkin, S. R. (2012). Neurofibromatoses. In S. Ahmad (Ed.), Neurodegenerative diseases (pp. 266–277). New York, NY: Spring Science Business Media.CrossRefGoogle Scholar
  6. 6.
    Piotrowski, A., Xie, J., Liu, Y. F., Poplawski, A. B., Gomes, A. R., Madanecki, P., et al. (2014). Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nature Genetics, 46, 182.PubMedCrossRefGoogle Scholar
  7. 7.
    Brems, H., Pasmant, E., Van Minkelen, R., Wimmer, K., Upadhyaya, M., Legius, E., et al. (2012). Review and update of SPRED1 mutations causing Legius syndrome. Human Mutation, 33(11), 1538–1546.PubMedCrossRefGoogle Scholar
  8. 8.
    Patil, S., & Chamberlain, R. S. (2012). Neoplasms associated with germline and somatic NF1 gene mutations. The Oncologist, 17(1), 101–116.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Leppig, K. A., Kaplan, P., Viskochil, D., Weaver, M., Ortenberg, J., & Stephens, K. (1997). Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. American Journal of Medical Genetics, 73(2), 197–204.PubMedCrossRefGoogle Scholar
  10. 10.
    Pasmant, E., Vidaud, M., Vidaud, D., & Wolkenstein, P. (2012). Neurofibromatosis type 1: From genotype to phenotype. Journal of Medical Genetics, 49(8), 483–489.PubMedCrossRefGoogle Scholar
  11. 11.
    Moles, K. J., Gowans, G. C., Gedela, S., Beversdorf, D., Yu, A., Seaver, A. H., et al. (2012). NF1 microduplications: Identification of seven nonrelated individuals provides further characterization of the phenotype. Genetics in Medicine, 14(5), 508–514.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of NeurologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.McKusick-Nathans Institute of Genetic MedicineJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations